Stock Analysis on Net

Humana Inc. (NYSE:HUM)

Income Statement
Quarterly Data

The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

Humana Inc., consolidated income statement (quarterly data)

US$ in millions

Microsoft Excel
3 months ended: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Premiums 25,128 25,099 25,495 25,550 21,275 21,468 22,266 22,703 19,835 19,885 19,978 20,124 18,364 18,904 18,556 18,362 15,809 15,712 15,776 15,651
Services 1,040 1,016 978 999 1,004 1,159 1,349 1,264 1,253 845 491 466 484 457 450 424 336 393 355 355
External revenues 26,168 26,115 26,473 26,549 22,279 22,627 23,615 23,967 21,088 20,730 20,469 20,590 18,848 19,361 19,006 18,786 16,145 16,105 16,131 16,006
Investment income (loss) 294 308 274 193 160 172 47 3 (34) (33) 176 78 214 714 77 149 150 136 114 101
Benefits (22,782) (21,745) (22,009) (21,858) (18,582) (18,384) (19,099) (19,625) (17,438) (17,316) (17,149) (17,296) (16,213) (15,611) (14,175) (15,629) (13,689) (13,357) (13,318) (13,493)
Operating costs (3,827) (3,271) (3,111) (2,979) (3,551) (3,061) (3,173) (2,886) (3,395) (2,603) (2,116) (2,007) (3,068) (2,513) (2,354) (2,117) (2,129) (1,889) (1,703) (1,660)
Depreciation and amortization (201) (201) (191) (186) (182) (182) (175) (170) (160) (150) (144) (142) (127) (128) (119) (115) (115) (127) (109) (107)
Operating expenses (26,810) (25,217) (25,311) (25,023) (22,315) (21,627) (22,447) (22,681) (20,993) (20,069) (19,409) (19,445) (19,408) (18,252) (16,648) (17,861) (15,933) (15,373) (15,130) (15,260)
Income from operations (348) 1,206 1,436 1,719 124 1,172 1,215 1,289 61 628 1,236 1,223 (346) 1,823 2,435 1,074 362 868 1,115 847
Gain on sale of Gentiva Hospice (3) 240
Interest expense (146) (114) (120) (113) (108) (102) (101) (90) (91) (88) (79) (68) (72) (75) (76) (60) (58) (62) (60) (62)
Other income (expense), net (97) 6 (54) 8 (84) (13) 8 21 (30) 1,096 (419) (115) (40) 7 227 (297) 289 82 174 (39)
Income before income taxes and equity in net earnings (losses) (591) 1,098 1,262 1,614 (71) 1,297 1,122 1,220 (60) 1,636 738 1,040 (458) 1,755 2,586 717 593 888 1,229 746
Provision for income taxes 75 (256) (296) (359) 58 (107) (427) (286) 51 (120) (183) (233) 178 (450) (783) (252) (79) (200) (301) (183)
Equity in net earnings (losses) (24) (12) (10) (17) (5) 3 2 (4) (4) 15 33 21 6 35 25 8 (2) 1 12 3
Net income (540) 830 956 1,238 (18) 1,193 697 930 (13) 1,531 588 828 (274) 1,340 1,828 473 512 689 940 566
Net (income) loss attributable to noncontrolling interests (1) 2 3 1 3 2 (1) (1)
Net income attributable to Humana (541) 832 959 1,239 (15) 1,195 696 930 (14) 1,531 588 828 (274) 1,340 1,828 473 512 689 940 566

Based on: 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

Income statement item Description The company
External revenues Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Humana Inc. external revenues decreased from Q2 2023 to Q3 2023 but then slightly increased from Q3 2023 to Q4 2023.
Income from operations The net result for the period of deducting operating expenses from operating revenues. Humana Inc. income from operations decreased from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023.
Income before income taxes and equity in net earnings (losses) Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Humana Inc. income before income taxes and equity in net earnings (losses) decreased from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023.
Net income attributable to Humana The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Humana Inc. net income attributable to Humana decreased from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023.